With experience in building, managing and providing financing for high technology and biotechnology companies, Genesys Capital has developed a strong business, professional and scientific network that provides practical insight into biotechnology-based opportunities.
Genesys' successful track record in venture investing, business development and life science research attracts high quality deal flow with significant growth potential. Genesys offers investors an exceptional opportunity to benefit from the biotechnology-fuelled growth expected in the healthcare and biotechnology industries.
Through its managed funds, Genesys invests in start-up and mid-stage investment opportunities across various sub sectors of the life sciences industry including biopharmaceuticals, medical devices and healthcare services.
Since its inception in 2000, Genesys has been one of the most active seed and start-up life sciences investors in Canada. Through its initial venture capital fund known as Fund I, Genesys has invested over $90 million in 18 life sciences companies and has been the lead and initial investor in over 90% of its early stage investments.